A double-blind study funded by Shire biopharmaceutical company found that one of its products, Vyvanse, could alleviate the symptoms of Attention Deficit Hyperactivity Disorder in children ages six to 12 years old.

Researchers divided a group of 129 children (ages six to 12 years old) with ADHD into two groups. One group received a placebo and the other group took Vyvanse. The children who took the drug had fewer symptoms for up to 12 hours than did the children who took the placebo.

Side effects of the drug are decreased appetite, insomnia, headaches, irritability, upper abdominal pain and affect ability.

The study appeared in the journal Child and Adolescent Psychiatry and Mental Health.

Labels: research, symptoms, drug_study

Posted By: Aspen/CRC 0 Comments

Makers of the drug Seroquel are attempting to keep sealed hundreds of pages of drug study results, saying it is in the public's best interest. About 15,000 patients who have been prescribed the drug disagree, and have filed over 9,000 personal injury lawsuits stating the drug has caused weight gain and diabetes.

"Seroquel is approved only for schizophrenia and bipolar disorder, but its use for everything from depression to insomnia to ADHD in kids is so widespread that the drug has been prescribed for more than 22 million patients."

The company's maker, AstraZeneca, says releasing the documents "could jeopardize public safety by causing confusion and alarm in patients, who may then discontinue their medication..." A hearing is scheduled to take place in Orlando this month - a hearing AstraZeneca wants closed to the public because sensitive information will be discussed. Source: St. Petersburg Times

Labels: medications, side_effects, drug_study

Posted By: Aspen Education Group 0 Comments